| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8963773 | The Journal of Allergy and Clinical Immunology: In Practice | 2018 | 12 Pages |
Abstract
In patients with frequent HAE attacks, a treatment strategy of routine prevention with self-administered twice weekly C1-INH(SC) had a greater impact on improving multiple HAE-related HRQoL impairments, most notably anxiety and work productivity, compared with on-demand treatment alone (placebo prophylaxis).
Keywords
TSQMMCIDHRQOLWPAIC1-INHHSVEQ-5D-3LC1-INH-HAEVASQuality of lifeC1-inhibitorHereditary angioedemastandard deviationProductivityHAEMinimal Clinically Important DifferenceIntravenousSatisfactionsubcutaneousShort formconfidence intervalvisual analog scaleHospital Anxiety and Depression ScalePatient-reported outcomespatient-reported outcomePROHADSHealth-related quality of life
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
William R. MD, Timothy DO, Bruce MD, Hilary MD, PhD, James MD, H. Henry MD, PhD, Jonathan A. MD, John MD, Marc A. MD, Michael E. MD, Paul K. MD, MSc, Donald S. MD, Teresa MD, PhD, Aleena MD, Richard G. MD, Henriette MD, PhD, DSc, John-Philip MSc,